Magainin Pharmaceuticals, Inc.

Enterin, Inc.

Other

The Children's Hospital of Philadelphia

Enterin Laboratories, Inc.

Genaera Corporation

The Children's Hospital of Pennsylvania

Formula Xo, Inc.

Ohr Pharmaceutical Inc.

Magainin Sciences Inc.

Mount Desert Island Biological Laboratory

Michael A Zasloff

William Alvin Kinney

Ann Shinnar

Jon I Williams

Mark L Anderson

Meena N Rao

Denise Barbut

Michael McLane

Steven Jones

Leah L Frye

Robert Moriarty

Barry S Schonwetter

W Lee Maloy

U Prasad Kari

Delwood C Collins

Glenn Mark Anderson

Charles L Bevins

Gill Diamond

James M Wilson

Barry Berkowitz

Ethan D Stolzenberg

Lincoln Noecker

Thomas Uzzell

Binyamin Feibush

Michael Brasseur

Mitchell H Sokoloff

Wallace H Steinberg

Viravuth Pho Yin

Robert Bals

Suzanne Wehrli

Mitchell Goldman

Karen Moore

Kevin B Strange

Prasad Kari

Nicole Resnick

The present application relates generally to novel aminosterol compounds, compositions comprising the same, and methods of making and using the novel aminosterol compounds and compositions.

Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same

The present application relates generally to methods for treating, preventing and/or slowing the onset or progression of schizophrenia and/or a related symptom. The methods comprise administering at least one aminosterol or a pharmaceutically acceptable salt or derivative thereof to a subject in need.

Aminosterol compositions and methods of using the same for treating schizophrenia

This invention relates to methods of stimulating the activity of the human and animal enteric nervous system. The method comprises orally administering an aminoserol, such as squalamine, a naturally occurring aminosterol isolated from, or derivatives thereof, to a subject in need.

Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same

A method of treating or preventing a systemic viral infection in a mammal by administering a pharmaceutically acceptable composition selected from the group consisting of squalamine, an active isomer thereof, and an active analogue thereof, via a dosing regimen that delivers effective antiviral concentrations of squalamine. Also compositions for achieving the systemic antiviral effect.

Methods for treating and preventing viral infections

This invention relates to methods of treating or preventing a sleep disorder, sleep disturbance, or related symptom in a subject with aminosterols or pharmaceutically acceptable salts or derivatives thereof. In particular, the disclosed methods generally comprise administering an aminosterol to a subject in need, thereby stimulating an aminosterol-induced CNS response to treat and/or prevent a sleep disorder, sleep disturbance, or related symptom.

Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions

Provided herein are crystalline solid forms of squalamine phosphate designated as Form 1 and Form 2, compositions containing one or both forms, and methods of their preparation and of their use.

Squalamine solid forms and methods of making the same

Methods of treating and preventing gastrointestinal motility disorders using aminosterols

This invention relates to methods of stimulating the activity of the human and animal enteric nervous system. The method comprises orally administering an aminosterol, such as squalamine, a naturally occurring aminosterol isolated from, or derivatives thereof, to a subject in need.

Methods of treating Parkinson's disease using aminosterols and compositions comprising the same

Methods and compositions for treating and preventing viral infections

Methods of treating and/or preventing affective disorders of the nervous system (depression) using aminosterols

Methods of treating and/or preventing neurodevelopmental disorders (autism) using aminosterols

A personal care composition for hair and skin applications includes an aqueous solution consisting essentially of aggregates of behentrimonium chloride and dihydroxypropyl PEG-5 linoleammonium chloride. The composition forms micro particles or aggregates of behentrimonium chloride that exhibits surprising distributive properties in aqueous solution of a nature beneficial to its application to hair or skin surfaces.

Simple micro-particulate suspension of behentrimonium chloride with favorable distributive and adsorptive properties

Growing community of inventors

Merion Station, PA, United States of America

Michael A Zasloff